Monsanto Company Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of $2.11 per share, a rise of 12.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $2.10. Between one and three months ago, the average estimate moved up. It has been unchanged at $2.11 during the last month. Analysts are projecting profit to rise by 18.6% compared to last year’s $3.51.
Past Earnings Performance: Last quarter, the company beat estimates by 4 cents, coming in at profit of 23 cents a share versus the estimate of net income of 19 cents a share. It marked the fourth straight quarter of beating estimates.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: On average, analysts predict $4.53 billion in revenue this quarter, a rise of 9.7% from the year-ago quarter. Analysts are forecasting total revenue of $12.94 billion for the year, a rise of 9.5% from last year’s revenue of $11.82 billion.
A Look Back: In the first quarter, profit rose to $126 million (23 cents a share) from $6 million (one cent a share) the year earlier, exceeding analyst expectations. Revenue rose 33.3% to $2.44 billion from $1.83 billion.
On the top line, the company is looking to extend some positive momentum with this earnings announcement. Revenue rose 6.1% in the second quarter of the last fiscal year, 21.2% in the third quarter of the last fiscal year and 16.4% in the fourth quarter before climbing again in the first quarter.
Stock Price Performance: Between January 3, 2012 and March 29, 2012, the stock price rose $7.27 (10.1%), from $71.64 to $78.91. The stock price saw one of its best stretches over the last year between December 30, 2011 and January 12, 2012, when shares rose for nine straight days, increasing 15% (+$10.49) over that span. It saw one of its worst periods between September 15, 2011 and September 23, 2011 when shares fell for seven straight days, dropping 9.5% (-$6.65) over that span.
Analyst Ratings: Optimism surrounds Monsanto Company, as 10 analysts rate it as a buy, one rates it as a sell, and seven rate it as a hold.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org